(-)-epigallocatechin 3-gallate multiple interactions ISO RGD:735365 6480464 [potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of XPO1 mRNA CTD PMID:22079256 1,2-dimethylhydrazine multiple interactions ISO RGD:732925 6480464 [1, 2-Dimethylhydrazine co-treated with Folic Acid] results in increased expression of XPO1 mRNA CTD PMID:22206623 17beta-estradiol increases expression ISO RGD:735365 6480464 Estradiol results in increased expression of XPO1 mRNA CTD PMID:16514628 2,2',4,4'-Tetrabromodiphenyl ether affects expression ISO RGD:732925 6480464 2 more ... CTD PMID:30294300 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO RGD:732925 6480464 Tetrachlorodibenzodioxin results in increased expression of XPO1 mRNA CTD PMID:19465110 2,3,7,8-tetrachlorodibenzodioxine increases expression EXP 6480464 Tetrachlorodibenzodioxin results in increased expression of XPO1 mRNA CTD PMID:33387578 , PMID:34747641 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO RGD:732925 6480464 Tetrachlorodibenzodioxin affects the expression of XPO1 mRNA CTD PMID:24680724 2,4-dinitrotoluene affects expression EXP 6480464 2, 4-dinitrotoluene affects the expression of XPO1 mRNA CTD PMID:21346803 2,6-dinitrotoluene affects expression EXP 6480464 2, 6-dinitrotoluene affects the expression of XPO1 mRNA CTD PMID:21346803 2-methylcholine affects expression ISO RGD:735365 6480464 beta-methylcholine affects the expression of XPO1 mRNA CTD PMID:21179406 4-(N-nitrosomethylamino)-1-(3-pyridyl)butan-1-one decreases expression ISO RGD:735365 6480464 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone results in decreased expression of XPO1 protein CTD PMID:20421341 4-amino-2,6-dinitrotoluene affects expression EXP 6480464 4-amino-2, 6-dinitrotoluene affects the expression of XPO1 mRNA CTD PMID:21346803 aconitine decreases expression EXP 6480464 Aconitine results in decreased expression of XPO1 protein CTD PMID:33236894 acrolein multiple interactions ISO RGD:735365 6480464 [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of XPO1 mRNA, [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of XPO1 mRNA CTD PMID:32699268 acrylamide increases expression ISO RGD:735365 6480464 Acrylamide results in increased expression of XPO1 mRNA CTD PMID:32763439 afimoxifene decreases expression ISO RGD:735365 6480464 afimoxifene results in decreased expression of XPO1 mRNA CTD PMID:16514628 aflatoxin B1 increases expression ISO RGD:732925 6480464 Aflatoxin B1 results in increased expression of XPO1 mRNA CTD PMID:19770486 aflatoxin M1 decreases expression ISO RGD:735365 6480464 Aflatoxin M1 results in decreased expression of XPO1 mRNA CTD PMID:30928695 AICA ribonucleotide multiple interactions ISO RGD:735365 6480464 AICA ribonucleotide promotes the reaction [ABL1 protein mutant form binds to XPO1 protein] more ... CTD PMID:33070465 all-trans-retinoic acid decreases expression ISO RGD:735365 6480464 Tretinoin results in decreased expression of XPO1 mRNA CTD PMID:18614847 alpha-pinene multiple interactions ISO RGD:735365 6480464 [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of XPO1 mRNA, [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of XPO1 mRNA CTD PMID:32699268 ammonium chloride affects expression EXP 6480464 Ammonium Chloride affects the expression of XPO1 mRNA CTD PMID:16483693 aristolochic acid A decreases expression ISO RGD:735365 6480464 aristolochic acid I results in decreased expression of XPO1 mRNA CTD PMID:33212167 arsenous acid multiple interactions ISO RGD:735365 6480464 Arsenic Trioxide promotes the reaction [XPO1 protein binds to YWHAQ protein] CTD PMID:33070465 aurantio-obtusin decreases expression ISO RGD:732925 6480464 aurantio-obtusin results in decreased expression of XPO1 mRNA CTD PMID:34718095 benzo[a]pyrene affects methylation ISO RGD:735365 6480464 Benzo(a)pyrene affects the methylation of XPO1 intron CTD PMID:30157460 benzo[a]pyrene diol epoxide I decreases expression ISO RGD:735365 6480464 7 more ... CTD PMID:19150397 more ... bisphenol A increases expression EXP 6480464 bisphenol A results in increased expression of XPO1 mRNA CTD PMID:25181051 , PMID:30816183 bisphenol A increases methylation ISO RGD:735365 6480464 bisphenol A results in increased methylation of XPO1 gene CTD PMID:31601247 bisphenol A decreases expression ISO RGD:732925 6480464 bisphenol A results in decreased expression of XPO1 mRNA CTD PMID:33221593 buspirone decreases expression EXP 6480464 Buspirone results in decreased expression of XPO1 mRNA CTD PMID:24136188 cadmium dichloride multiple interactions ISO RGD:732925 6480464 XPO1 protein affects the reaction [Cadmium Chloride affects the localization of BACH1 protein] CTD PMID:14504288 cadmium dichloride decreases expression EXP 6480464 Cadmium Chloride results in decreased expression of XPO1 mRNA CTD PMID:33453195 caffeine decreases phosphorylation ISO RGD:735365 6480464 Caffeine results in decreased phosphorylation of XPO1 protein CTD PMID:35688186 calcitriol decreases expression ISO RGD:735365 6480464 Calcitriol results in decreased expression of XPO1 mRNA CTD PMID:16847355 , PMID:18614847 cannabidiol multiple interactions ISO RGD:735365 6480464 [Cuprizone co-treated with Cannabidiol] results in decreased expression of XPO1 protein CTD PMID:34122009 cannabidiol increases expression ISO RGD:735365 6480464 Cannabidiol results in increased expression of XPO1 mRNA CTD PMID:31801206 chloropicrin increases expression ISO RGD:735365 6480464 chloropicrin results in increased expression of XPO1 mRNA CTD PMID:26352163 chloroquine multiple interactions ISO RGD:735365 6480464 Chloroquine promotes the reaction [XPO1 protein binds to BECN1 protein], Chloroquine promotes the reaction [XPO1 protein binds to YWHAQ protein] CTD PMID:33070465 chlorpyrifos increases expression ISO RGD:732925 6480464 Chlorpyrifos results in increased expression of XPO1 mRNA CTD PMID:34289071 ciguatoxin CTX1B affects expression ISO RGD:732925 6480464 Ciguatoxins affects the expression of XPO1 mRNA CTD PMID:18353800 clofibrate increases expression ISO RGD:732925 6480464 Clofibrate results in increased expression of XPO1 mRNA CTD PMID:17585979 copper atom increases expression EXP 6480464 Copper results in increased expression of XPO1 mRNA CTD PMID:22465980 , PMID:30556269 copper(0) increases expression EXP 6480464 Copper results in increased expression of XPO1 mRNA CTD PMID:22465980 , PMID:30556269 corticosterone decreases expression EXP 6480464 Corticosterone results in decreased expression of XPO1 mRNA CTD PMID:15755911 coumarin affects phosphorylation ISO RGD:735365 6480464 coumarin affects the phosphorylation of XPO1 protein CTD PMID:35688186 crocidolite asbestos decreases expression ISO RGD:732925 6480464 Asbestos, Crocidolite results in decreased expression of XPO1 mRNA CTD PMID:29279043 Cuprizon multiple interactions ISO RGD:735365 6480464 [Cuprizone co-treated with Cannabidiol] results in decreased expression of XPO1 protein CTD PMID:34122009 curcumin multiple interactions ISO RGD:732925 6480464 Curcumin inhibits the reaction [KRAS protein results in decreased expression of XPO1 protein] CTD PMID:21519798 diarsenic trioxide multiple interactions ISO RGD:735365 6480464 Arsenic Trioxide promotes the reaction [XPO1 protein binds to YWHAQ protein] CTD PMID:33070465 dibutyl phthalate decreases expression ISO RGD:732925 6480464 Dibutyl Phthalate results in decreased expression of XPO1 mRNA CTD PMID:21266533 dicrotophos decreases expression ISO RGD:735365 6480464 dicrotophos results in decreased expression of XPO1 mRNA CTD PMID:28302478 doxorubicin multiple interactions EXP 6480464 Doxorubicin promotes the reaction [MIRLET7F-2 mRNA results in decreased expression of XPO1 mRNA] more ... CTD PMID:31570982 doxorubicin decreases expression EXP 6480464 Doxorubicin results in decreased expression of XPO1 mRNA, Doxorubicin results in decreased expression of XPO1 protein CTD PMID:31570982 enzyme inhibitor multiple interactions ISO RGD:735365 6480464 [Enzyme Inhibitors results in decreased activity of OGA protein] which results in increased O-linked glycosylation of XPO1 protein CTD PMID:23301498 ethanol affects expression ISO RGD:732925 6480464 Ethanol affects the expression of XPO1 mRNA CTD PMID:30319688 finasteride increases expression EXP 6480464 Finasteride results in increased expression of XPO1 mRNA CTD PMID:24136188 fluoxetine decreases expression EXP 6480464 Fluoxetine results in decreased expression of XPO1 mRNA CTD PMID:21852994 fluoxetine increases expression EXP 6480464 Fluoxetine results in increased expression of XPO1 mRNA CTD PMID:21852994 flutamide increases expression EXP 6480464 Flutamide results in increased expression of XPO1 mRNA CTD PMID:24136188 folic acid multiple interactions ISO RGD:732925 6480464 [1, 2-Dimethylhydrazine co-treated with Folic Acid] results in increased expression of XPO1 mRNA CTD PMID:22206623 fulvestrant decreases expression ISO RGD:735365 6480464 fulvestrant results in decreased expression of XPO1 mRNA CTD PMID:16514628 furan increases expression EXP 6480464 furan results in increased expression of XPO1 mRNA CTD PMID:25539665 , PMID:26194646 gentamycin increases expression EXP 6480464 Gentamicins results in increased expression of XPO1 mRNA CTD PMID:33387578 hydrogen peroxide affects expression ISO RGD:735365 6480464 Hydrogen Peroxide affects the expression of XPO1 mRNA CTD PMID:20044591 ivermectin decreases expression ISO RGD:735365 6480464 Ivermectin results in decreased expression of XPO1 protein CTD PMID:32959892 leflunomide increases expression EXP 6480464 leflunomide results in increased expression of XPO1 mRNA CTD PMID:24136188 leptomycin B multiple interactions ISO RGD:732925 6480464 [leptomycin B results in decreased activity of XPO1 protein] which results in decreased export of SMAD4 protein CTD PMID:26354774 leptomycin B decreases activity ISO RGD:732925 6480464 leptomycin B results in decreased activity of XPO1 protein CTD PMID:26354774 levofloxacin decreases expression EXP 6480464 Levofloxacin results in decreased expression of XPO1 mRNA CTD PMID:24136188 menadione affects expression ISO RGD:735365 6480464 Vitamin K 3 affects the expression of XPO1 mRNA CTD PMID:20044591 methidathion decreases expression ISO RGD:732925 6480464 methidathion results in decreased expression of XPO1 mRNA CTD PMID:34813904 methylparaben increases expression ISO RGD:735365 6480464 methylparaben results in increased expression of XPO1 mRNA CTD PMID:31745603 miconazole decreases expression ISO RGD:732925 6480464 Miconazole results in decreased expression of XPO1 mRNA CTD PMID:27462272 N-methyl-4-phenylpyridinium increases expression ISO RGD:735365 6480464 1-Methyl-4-phenylpyridinium results in increased expression of XPO1 mRNA CTD PMID:24810058 nefazodone increases expression EXP 6480464 nefazodone results in increased expression of XPO1 mRNA CTD PMID:24136188 nickel atom decreases expression ISO RGD:735365 6480464 Nickel results in decreased expression of XPO1 mRNA CTD PMID:23195993 nimesulide increases expression EXP 6480464 nimesulide results in increased expression of XPO1 mRNA CTD PMID:24136188 oxaliplatin multiple interactions EXP 6480464 [oxaliplatin co-treated with Topotecan] results in decreased expression of XPO1 mRNA CTD PMID:25729387 ozone multiple interactions ISO RGD:735365 6480464 [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of XPO1 mRNA more ... CTD PMID:32699268 paclitaxel decreases expression ISO RGD:735365 6480464 Paclitaxel results in decreased expression of XPO1 mRNA CTD PMID:15000894 paracetamol affects expression ISO RGD:732925 6480464 Acetaminophen affects the expression of XPO1 mRNA CTD PMID:17562736 phenobarbital affects expression ISO RGD:735365 6480464 Phenobarbital affects the expression of XPO1 mRNA CTD PMID:19159669 PhIP increases expression EXP 6480464 2-amino-1-methyl-6-phenylimidazo(4, 5-b)pyridine results in increased expression of XPO1 mRNA CTD PMID:15215175 potassium chromate decreases expression ISO RGD:735365 6480464 potassium chromate(VI) results in decreased expression of XPO1 mRNA CTD PMID:22079256 potassium chromate multiple interactions ISO RGD:735365 6480464 [potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of XPO1 mRNA CTD PMID:22079256 potassium dichromate affects expression ISO RGD:732925 6480464 Potassium Dichromate affects the expression of XPO1 mRNA CTD PMID:23608068 propiconazole increases expression ISO RGD:732925 6480464 propiconazole results in increased expression of XPO1 mRNA CTD PMID:21278054 quercetin decreases expression ISO RGD:735365 6480464 Quercetin results in decreased expression of XPO1 mRNA CTD PMID:21632981 raloxifene decreases expression ISO RGD:735365 6480464 Raloxifene Hydrochloride results in decreased expression of XPO1 mRNA CTD PMID:16514628 resveratrol decreases expression ISO RGD:732925 6480464 resveratrol results in decreased expression of XPO1 protein CTD PMID:25505154 sodium arsenite decreases expression ISO RGD:732925 6480464 sodium arsenite results in decreased expression of XPO1 mRNA, sodium arsenite results in decreased expression of XPO1 protein CTD PMID:32991915 sodium arsenite multiple interactions ISO RGD:732925 6480464 [sodium arsenite binds to ID3 protein] promotes the reaction [XPO1 protein affects the localization of ID3 protein] CTD PMID:23523789 sodium dichromate increases expression EXP 6480464 sodium bichromate results in increased expression of XPO1 mRNA CTD PMID:25993096 sulindac multiple interactions EXP 6480464 [Sulindac co-treated with lipopolysaccharide, E coli O55-B5] affects the expression of XPO1 mRNA CTD PMID:20371263 tetrachloromethane increases expression ISO RGD:732925 6480464 Carbon Tetrachloride results in increased expression of XPO1 mRNA CTD PMID:27339419 tetrachloromethane affects expression ISO RGD:732925 6480464 Carbon Tetrachloride affects the expression of XPO1 mRNA CTD PMID:31919559 thapsigargin decreases expression EXP 6480464 Thapsigargin results in decreased expression of XPO1 protein CTD PMID:35544339 thioacetamide increases expression EXP 6480464 Thioacetamide results in increased expression of XPO1 mRNA CTD PMID:23411599 , PMID:34492290 titanium dioxide decreases expression ISO RGD:732925 6480464 titanium dioxide results in decreased expression of XPO1 mRNA CTD PMID:29264374 topotecan multiple interactions EXP 6480464 [oxaliplatin co-treated with Topotecan] results in decreased expression of XPO1 mRNA CTD PMID:25729387 trichloroethene increases methylation EXP 6480464 Trichloroethylene results in increased methylation of XPO1 gene CTD PMID:27618143 trichostatin A affects expression ISO RGD:735365 6480464 trichostatin A affects the expression of XPO1 mRNA CTD PMID:28542535 triptonide increases expression ISO RGD:732925 6480464 triptonide results in increased expression of XPO1 mRNA CTD PMID:33045310 trovafloxacin decreases expression EXP 6480464 trovafloxacin results in decreased expression of XPO1 mRNA CTD PMID:24136188 valproic acid decreases expression ISO RGD:735365 6480464 Valproic Acid results in decreased expression of XPO1 mRNA CTD PMID:23179753 more ... vinclozolin increases expression EXP 6480464 vinclozolin results in increased expression of XPO1 mRNA CTD PMID:23034163
